[1] Aloman C,Tacke R. Dendritic cells in liver fibrosis:conductor of the inflammatory orchestra Hepatology,2010,51(3):1070-1072. [2] Coquerelle C,Moser M. DC subsets in positive and negative regulation of immunity. Immunol Rev,2010,234(1):317-334. [3] Langer-Gould A,Gupta R,Huang S,et al. Interferon-gamma-producing T cells,pregnancy,and postpartum relapses of multiple sclerosis. Arch Neurol,2010,67(1):51-57. [4] Lin LC,Sibille E. Reduced brain somatostatin in mood disorders:a common pathophysiological substrate and drug target Front Pharmacol,2013,9(4):110-114. [5] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2010年版). 实用肝脏病杂志,2011,14(2):81-89. [6] 郑盛,杨晋辉.慢加急性肝衰竭发病机制研究进展. 中国肝脏病杂志(电子版),2012,3(3):61-64. [7] 郑盛,宁珠. 原发性肝癌患者CD4CD25调节性T细胞及转化生长因子β1检测. 中国肝脏病杂志(电子版),2012,3(4):9-12. [8] Marakami R,Denda-Nagai K,Hashimoto S,et al. A unique dermal dendritic cell subset that skews the immune response toward Th2. PLoS One,2013,8(9):e73270. [9] Grainger JR,Hall JA,Bouladoux N,et al. Microbe-dendritic cell dialog controls regulatory T-cell fate. Immunol Rev,2010,234:305-316. [10] 赖小欢. 树突状细胞与慢性乙型肝炎.实用肝脏病杂志,2011,14(5):386-389. [11] Ma YJ,He M,Han JA,et al. A clinical study of HBeAg-activated dendritic cells and cytokine-induced killer cells during the treatment for chronic hepatitis B. Scand J Immunol,2013,78(4):387-393. [12] Su ZJ,Yu XP,Guo RY,et al. Changes in the balance between Treg and Th17 cells in patients with chronic hepatitis B. Diagn Microbiol Infect Dis,2013,76(4):437-444. [13] 孙学华,刘巧丽,李曼,等. 慢性乙型肝炎患者CD4 + 和CD8 + 细胞亚群的研究. 细胞与分子免疫学杂志,2011,27(5):157-159. [14] Stoop JN,van der Molen RG,Baan CC,et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology,2005,41(4):771-778. [15] Bertoletti A,Gehring AJ. The immune response during hepatitis B virus infection. Gen Virol,2006,87(6):1439-1449. [16] Akbar SM,Horike N,Onji M. Immune therapy including dendritic cell based therapy in therapy in chronic hepatitis B. World Gastroenterol,2006,12(18):2876-2883. [17] You J,Sriplung H,Geater A,et al. Impact of viral replication inhibition by entecavir on peripheral T lymphocyte subpopulations in chronic hepatitis B patients. BMC Infect Dis,2008,22(8):123. [18] 尹燕耀,肖影群,宋高峰. 慢性乙型肝炎患者肝组织内CD4 + 、CD8 + T淋巴细胞的表达特点. 临床荟萃,2010,25(6):512-513. [19] Krebs K,Bottinger N,Huang LR,et al. T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice. Gastroenterlolgy,2013,145(2):456-465. [20] 韩悦,张欣欣. 乙型肝炎病毒感染的固有免疫反应. 肝脏,2012,17(1):44-46. |